Safety Study of GenSci155 Injection in Healthy Adults
This is an early-stage safety study testing a new injectable medication (GenSci155) that affects growth and metabolism. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in patients with medical conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be healthy overall with no serious medical conditions, allergies to growth factors, or history of low blood sugar
- You must be between 18 and 60 years old, weigh at least 50 kg (men) or 45 kg (women), and have a normal BMI (roughly 19–28)
- You cannot be pregnant, breastfeeding, or planning to conceive in the next 3 months; must use contraception if of childbearing age
- You must pass all screening tests: blood work, heart rhythm (ECG), chest X-ray, and tests for infections like HIV and hepatitis
- You cannot smoke, drink heavily, use recreational drugs, or take most medications (including vitamins and herbal supplements) during the study
- You must commit to attending all study visits, have accessible veins for blood draws, and no visible skin issues (tattoos, scars, sunburn) at the injection site
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called GenSci164 in healthy adults. It helps find out how the drug works in the body and if it is safe. Participants receive the injection and are monitored for effects.
This early-phase trial tests a new injection called GB18 in healthy adults to see if it is safe and how the body processes it. It may help researchers understand how to treat conditions that involve the immune system.
This trial tests a new growth hormone treatment called GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD). The goal is to see if it is safe and effective for people who need growth hormone replacement.
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
This trial tests a new injection called GR2301 to see if it is safe in healthy people. Volunteers will help researchers understand any side effects before the drug is given to patients with a disease.
This trial tests a new medicine called GenSci161 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 45 who are willing to follow study rules and use birth control.
Hear when a new Healthy Adult Trial Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.